Indian pharma market back to pre-Covid level in FY23

The Indian Pharma Market (IPM) growth has normalised to 9.3 per cent in FY23, bringing it at par to the pre-pandemic years of FY19 and FY20 according to a report

by Aditya Ghosalkar